aTyr Pharma, Inc.ATYRNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-62.06M
↓ 51% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-40.99M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-62.06M | +10.3% |
| 2024 | $-69.18M | -84.8% |
| 2023 | $-37.44M | +14.0% |
| 2022 | $-43.53M | -30.8% |
| 2021 | $-33.27M | -114.6% |
| 2020 | $-15.50M | +22.8% |
| 2019 | $-20.09M | +36.5% |
| 2018 | $-31.66M | +27.5% |
| 2017 | $-43.68M | +18.3% |
| 2016 | $-53.46M | - |